 |
|
Protein from tick saliva studied for potential myasthenia gravis treatment
March 26, 2009Looking for a better treatment for the autoimmune disease myasthenia gravis, researchers have found that a protein in tick saliva shows promise in limiting the severity of the disease in an animal model in a study published in the Annals of Neurology.
"This disease can leave patients weak and on breathing machines, and conventional treatments can be toxic," said Henry Kaminski, M.D., chair of the department of neurology and psychiatry at Saint Louis University and one of the nation's leading experts on myasthenia gravis. "There is a real need for better treatments. This study is a step in that direction."
Myasthenia gravis is a highly debilitating, chronic neuromuscular disorder that affects about 400 to 600 per 1 million people, and roughly 1,100 to 1,700 people in the St. Louis area. Symptoms include weakness in the arms and legs, chronic muscle fatigue, difficulty breathing, difficulty chewing and swallowing, slurred speech, droopy eyelids and blurred or double vision.
While drugs like prednisone, a corticosteroid, can be effective in treating the disorder, they also can carry a host of severe side effects, including pronounced weight gain, osteoporosis, glaucoma and diabetes.
Other treatments, intravenous immunoglobulin and plasmapheresis, which involve blood plasma, are expensive and can have rare but serious side-effects such as infections, heart attacks and stroke.
Doctors believe that myasthenia gravis is caused by an overreaction of the complement system, a component of the immune system that specifically defends against parasites, bacteria and other pathogens. Antibodies block nerve receptors at the neuromuscular junction, the place where nerves connect with muscles, and then activate complement which prevents muscle contraction from occurring, causing weakness.
To impede the complement system's misplaced response, researchers hope a new class of drugs, called complement inhibitors, may stop the body's defense system from attacking itself.
Other researchers discovered that rEV576, a protein found in tick saliva, works as a complement inhibitor, allowing ticks to avoiding setting off an immune response in their human host.
SLU researchers in collaboration with Varleigh Limited tested the protein on two groups of rats with mild and severe models of myasthenia gravis. The health of rats that were given the complement inhibitor rEV576 improved, with reduced weakness and weight loss.
Researchers hope rEV576 could have therapeutic value in human myasthenia gravis. And, because ticks apply themselves to people without causing a reaction, researchers are optimistic that rEV576 will not cause allergic reactions or other negative side effects.
"Complement inhibitors are a completely new class of drugs," said Kaminski. "This one will probably prove to be superior to what we've seen. Since complement is activated in many diseases such as Alzheimer's, stroke and rheumatoid arthritis, our studies may be important for other diseases."
Saint Louis University
While drugs like prednisone, a corticosteroid, can be effective in treating the disorder, they also can carry a host of severe side effects, including pronounced weight gain, osteoporosis, glaucoma and diabetes.
Other treatments, intravenous immunoglobulin and plasmapheresis, which involve blood plasma, are expensive and can have rare but serious side-effects such as infections, heart attacks and stroke.
Doctors believe that myasthenia gravis is caused by an overreaction of the complement system, a component of the immune system that specifically defends against parasites, bacteria and other pathogens. Antibodies block nerve receptors at the neuromuscular junction, the place where nerves connect with muscles, and then activate complement which prevents muscle contraction from occurring, causing weakness.
To impede the complement system's misplaced response, researchers hope a new class of drugs, called complement inhibitors, may stop the body's defense system from attacking itself.
Other researchers discovered that rEV576, a protein found in tick saliva, works as a complement inhibitor, allowing ticks to avoiding setting off an immune response in their human host.
SLU researchers in collaboration with Varleigh Limited tested the protein on two groups of rats with mild and severe models of myasthenia gravis. The health of rats that were given the complement inhibitor rEV576 improved, with reduced weakness and weight loss.
Researchers hope rEV576 could have therapeutic value in human myasthenia gravis. And, because ticks apply themselves to people without causing a reaction, researchers are optimistic that rEV576 will not cause allergic reactions or other negative side effects.
"Complement inhibitors are a completely new class of drugs," said Kaminski. "This one will probably prove to be superior to what we've seen. Since complement is activated in many diseases such as Alzheimer's, stroke and rheumatoid arthritis, our studies may be important for other diseases."
Saint Louis University
Myasthenia Gravis Current Events and Myasthenia Gravis News RSS'HiCy' drug regimen reverses ms symptoms in selected patients
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report.
SLU researchers show how to stop muscle weakness caused by myasthenia gravis
Severe muscle weakness caused by myasthenia gravis - a highly debilitating autoimmune disorder - can be prevented or reversed by blocking a key step in the immune response that brings on the disease, researchers at the Saint Louis University School of Medicine have found.
DNA vaccine against multiple sclerosis appears safe, potentially beneficial
A newly developed DNA vaccine appears safe and may produce beneficial changes in the brains and immune systems of individuals with multiple sclerosis.
Short-term yoga training expands breathing and lung capacity in young, healthy adults
Young and healthy Thais who participated in just 18 short yoga sessions showed significant improvements on six of seven measures of respiratory function, according to research from Khon Kaen University.
Researchers map of genetic variations implicated in disease
Sequence differences in less than 0.2% of the 3-billion-base human genome play a vital role in a bewildering variety of human disease.
Novel and Effective Treatment for Soft Tissue Sarcoma in Children
Rhabdomyosarcoma is a highly malignant aggressive form of soft tissue cancer in children, the causes of which are currently unknown. Although the fibrous growths can be found all over the body they commonly develop around the head, neck, bladder and testes in young boys. The most common age for onset is between 1-5 years of age. The treatments used are usually chemotherapy using a combination of drugs, radiotherapy and surgery and although quite effective (66% success rate at present), the side affects commonly experienced by the young patients are very unpleasant and the whole process can prove to be very traumatic not only for the patient but for the families too. So there is a need for a
More Myasthenia Gravis Current Events and Myasthenia Gravis News Articles
 |
The Mysterious Illness-Myasthenia Gravis by Hazel Smart (Author) The writer suffers from a rare autoimmune condition called Myasthenia Gravis. It is a neuromuscular disease in which the body generates an immune system attack against its own skeletal muscles. 14 out of every 100,000 persons in the USA suffer from this. The muscles of the body that are controlled by nerve impulses in the brain travel down the nerves where they meet the muscle fiber at the neuromuscular junction. When the nerve impulse from the brain arrives at the junction they release a chemical that tells the muscles to move. When the muscles do not receive the message from the brain because antibodies destroy the chemical, the muscles become weak and cannot perform. Stress, tiredness, depression or just fighting a cold can trigger an attack.She has struggled out of a wheelchair and... |
 |
Myasthenia Gravis Medical Guide by Qontro Medical Guides (Author) The Myasthenia Gravis Medical Guide is a publication which has been designed to better help readers understand Myasthenia Gravis. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Myasthenia Gravis. The Myasthenia Gravis Medical Guide is highly recommended for those interested in understanding and learning more about Myasthenia Gravis. |
 |
Myasthenia Gravis Awareness Ribbon Mouse Pad by MyHeritageWear.com The Myasthenia Gravis Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Myasthenia Gravis Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Myasthenia Gravis Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
The Official Patient's Sourcebook on Myasthenia Gravis: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to myasthenia gravis (also Erb-Goldflam syndrome; Myasthenia Gravis Pseudoparalytica), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on myasthenia gravis. Given patients'... |
 |
Attacking Myasthenia Gravis by Dr. Ronald E. Henderson (Author) Using his insight as a longtime physician, Dr. Ron Henderson describes the productive life he lives despite having a rare autoimmune disease known as myasthenia gravis (MG). He also provides a forum for three other MG patients to share their inspirational stories. A disease unfamiliar to many, myasthenia gravis means "grave muscle weakness" and causes severe weakness and loss of strength in voluntary muscles in various parts of the body. Often debilitating, MG falls into the category of "autoimmune" diseases, which all involve problems related to the immune system. Explaining MG symptoms, treatments, research, and disease-management tips, this book becomes a useful guide for MG patients, their families, and their physicians. And the book goes further. Using MG as an example, Dr. Henderson... |
 |
Myasthenia Gravis and Related Disorders (Current Clinical Neurology) by Henry J. Kaminski (Editor) Advances in the study and understanding of myasthenia gravis have led to the need for the publication of this important new edition. The goal of Myasthenia Gravis and Related Disorders, Second Edition is identical to the first -- to provide the clinician and the scientist with a common resource for understanding this complex disorder. This new edition begins with discussions of neuromuscular junction structure and function and follows with updated chapters covering a wide range of topics, such as the acetylcholine receptor, clinical presentation, diagnostic evaluation, and treatment. Importantly, new supplemental chapters have been added; these discuss rigorous clinical assessments of patients for research trials and the epidemiology and genetics of myasthenia gravis. The discussion of... |
 |
Living Well with Autoimmune Disease: What Your Doctor Doesn't Tell You...That You Need to Know by Mary J. Shomon (Author) Are you tired? Achy? Depressed? Overweight? You could be suffering from an autoimmune disease. Autoimmune disease is the third major category of illness in the United States, yet very little is known about the many serious and chronic immune conditions. If you're one of the 50 million Americans suffering from one kind of autoimmune disease-whether it's lupus, rheumatoid arthritis, multiple sclerosis, thyroid disease, fibromyalgia, chronic fatigue syndrome, or Crohn's disease-there's a good chance you'll develop another. This book can help. Written by Mary J. Shomon, a well-known patient advocate who was diagnosed with autoimmune disease in 1995, this guide to alternative and natural remedies shows you how to treat the underlying causes of immune system... |
 |
Myasthenia Gravis and Myasthenic Disorders (Contemporary Neurology Series) by Andrew G. Engel (Editor) This volume of the Contemporary Neurology Series presents an in-depth survey of presently recognized myasthenic disorders. The book begins with a description of the approach to diseases of the neuromuscular junction, surveying the anatomy and molecular architecture of the neuromuscular junction, the structure and kinetic properties of the acetylcholine receptor, and the electromyographic investigation of defects of neuromuscular transmission. The second section reviews the immunopathogenesis, experimental models, natural history, diagnosis, and treatment of autoimmune myasthenia gravis. The third section focuses on the clinical electrophysiologic, and, where relevant, the molecular genetic features of the Lambert-Eaton syndrome, the presynaptic, synaptic, and postsynaptic varieties of... |
|
Self-care actions to manage fatigue among myasthenia gravis patients.: An article from: Journal of Neuroscience Nursing by Mary Ellen Grohar-Murray (Author), Ann Becker (Author), Sarah Reilly (Author), Marilyn Ricci (Author) This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on June 1, 1998. The length of the article is 6099 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. From the supplier: Myasthenia gravis (MG) patients use aerobic exercise, self-pacing, stress reduction, and increased rest to relieve disease-associated fatigue. Researcher used two fatigue assessment scales to determine fatigue management strategies used by 250 patients with MG. Although aerobic exercise is often contraindicated for patients with MG, it may be helpful in the... | |
 |
Myasthenia Gravis: An Illustrated History by M.D., John C. Keesey (Author) 120 pages, case bound with full dust jacket. 9" x 12". Over 160 illustrations, drawings, diagrams, and charts, chronicling the history of the research and treatment of this disease. Each page is individually designed to best showcase its rare and rich imagery and insightfully written text. This book is based on the six large posters Dr. Keesey originally created in order to exhibit the history of MG to lay people in North America and Europe. The book is printed on the finest coated matt paper, with a smythe-sewn hard bound casing with head & tail bands. Interior images (160) are printed in duo-tone color. It ships with a full color dust jacket (French folded) and individual shrink wrapping. |
| © 2009 BrightSurf.com |